Raras
Buscar doenças, sintomas, genes...
Colangiocarcinoma peri-hilar
ORPHA:99978CID-10 · C24.0CID-11 · 2C18.0DOENÇA RARA

Um câncer nas vias biliares que surge exatamente ou muito próximo ao local onde os dois principais canais que levam a bile do fígado (o direito e o esquerdo) se juntam.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um câncer nas vias biliares que surge exatamente ou muito próximo ao local onde os dois principais canais que levam a bile do fígado (o direito e o esquerdo) se juntam.

Pesquisas ativas
17 ensaios
92 total registrados no ClinicalTrials.gov
Publicações científicas
1.149 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C24.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
3 sintomas
🩸
Sangue
2 sintomas
📏
Crescimento
1 sintomas

+ 4 sintomas em outras categorias

Características mais comuns

90%prev.
Icterícia
Muito frequente (99-80%)
90%prev.
Colangiocarcinoma
Muito frequente (99-80%)
90%prev.
Colestase extra-hepática
Muito frequente (99-80%)
55%prev.
Hepatomegalia
Frequente (79-30%)
55%prev.
Linfadenopatia
Frequente (79-30%)
17%prev.
Perda de peso
Ocasional (29-5%)
10sintomas
Muito frequente (3)
Frequente (2)
Ocasional (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 10 características clínicas mais associadas, ordenadas por frequência.

IcteríciaJaundice
Muito frequente (99-80%)90%
ColangiocarcinomaCholangiocarcinoma
Muito frequente (99-80%)90%
Colestase extra-hepáticaExtrahepatic cholestasis
Muito frequente (99-80%)90%
HepatomegaliaHepatomegaly
Frequente (79-30%)55%
LinfadenopatiaLymphadenopathy
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.149PubMed
Últimos 10 anos200publicações
Pico2025133 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 31
2Fase 26
·Pré-clínico12
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Colangiocarcinoma peri-hilar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

92 ensaios clínicos encontrados, 17 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.043 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.043

#1

Differences in Right Hepatic Duct Length Among Left-Sided Hepatectomies: Conventional Hepatectomy Versus Extended Hepatectomy Versus Trisectionectomy.

Journal of hepato-biliary-pancreatic sciences2026 Mar 08

Left-sided hepatectomy for perihilar cholangiocarcinoma includes conventional left hepatectomy (C-LH; H1234-B), extended left hepatectomy (E-LH; H12345'8'-B-MHV), and left trisectionectomy (LT; H123458-B). The anatomical characteristics of the resected length of the right hepatic duct (RHD) in E-LH remain unclear. This study aimed to characterize the length of the RHD across procedures. Patients who underwent left-sided hepatectomy for perihilar tumors between 2015 and 2023 were retrospectively reviewed. The shortest distance between the proximal bile duct stump and left hepatic duct orifice was measured on the resected specimens. The lengths and clinicopathological features of the procedures were compared. In total, 205 patients were included: C-LH (n = 80), E-LH (n = 53), and LT (n = 72). The length of the right anterior hepatic duct was longer in E-LH than that in C-LH (15.2 vs. 13.0 mm, p = 0.006). Similarly, the length of the right posterior hepatic duct increased stepwise from C-LH to E-LH and LT (13.3, 16.6, and 20.0 mm, respectively). E-LH is an intermediate procedure between C-LH and LT with respect to the resected length of the RHD. The additional bile duct length achieved by E-LH is minimal, and this procedure should be selected primarily to secure the parenchymal margin rather than ductal clearance.

#2

Long-term survival after multidisciplinary treatment including durvalumab for recurrent perihilar cholangiocarcinoma.

Clinical journal of gastroenterology2026 Mar 04

Perihilar cholangiocarcinoma is an aggressive malignancy with a poor prognosis even after curative resection, and recurrence is common. Systemic chemotherapy has long been the standard treatment for recurrent disease, but durable survival is rare. Recently, immune checkpoint inhibitors (ICIs) have been incorporated into first-line regimens for advanced biliary tract cancer, showing promising efficacy. We report a 61-year-old man who underwent extended left hepatectomy with caudate lobectomy, bile duct resection, and portal vein reconstruction for stage IVA perihilar cholangiocarcinoma. Twelve months later, para-aortic lymph node recurrence was detected and treated with gemcitabine plus cisplatin (GC), followed by S-1 and proton beam therapy for local recurrence. At 41 months post‑diagnosis, new intrahepatic metastases developed, and GC‑durvalumab (GCD) therapy was initiated. All lesions achieved radiological complete response within 2 years, with only grade 1 skin toxicity. The patient remains alive and well at 65 months after surgery and 53 months after recurrence, with sustained disease control. This case highlights the potential role of ICIs within multidisciplinary treatment strategies, demonstrating that even recurrent perihilar cholangiocarcinoma may achieve clinical complete response and long-term survival.

#3

The rise of transplant oncology in primary liver cancer and metastatic disease.

Hepatology (Baltimore, Md.)2026 Feb 25

Liver transplantation has evolved from a treatment restricted to patients with end-stage liver disease to a therapeutic option for selected patients with primary and metastatic liver malignancies. This review explores the rapidly expanding field of transplant oncology, highlighting its role in hepatocellular carcinoma, colorectal liver metastasis, neuroendocrine liver metastasis, and intra-hepatic and perihilar cholangiocarcinoma. Emphasis is placed on strategies to broaden eligibility, optimize donor organ use, and improve oncologic outcomes. We synthesized current evidence from clinical series, registries, and experimental protocols to evaluate patient selection criteria, outcomes, and peri-transplant management. Key topics include downstaging approaches to meet transplant criteria such as locoregional therapies and systemic regimens, and their prognostic implications. Advances in donor utilization have been analyzed for their capacity to expand the graft pool. Additionally, the review addresses the integration of oncologic principles into immunosuppression regimens, balancing graft protection with cancer control. Collectively, the reported studies demonstrate improved survival and reduced recurrence when stringent selection and multimodal therapy were applied. Transplant oncology reshapes the therapeutic landscape of liver malignancies, with growing evidence supporting liver transplantation in carefully selected patients beyond traditional indications. Optimized downstaging, innovative donor strategies, and tailored immunosuppression are pivotal for safe expansion. Continued collaboration between the transplant and oncology disciplines, along with prospective trials, is essential to further define standardized protocols and solidify transplantation as a cornerstone of multidisciplinary cancer care.

#4

Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2026 Feb 21

Accurate descriptions of the extent of disease in intrahepatic bile ducts are essential for managing patients with perihilar cholangiocarcinoma (pCCA). This study describes and assesses a new, automated Computed Tomography (CT)-scan-based 3D reconstruction process (3DR) of biliary tree in these patients compared with magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP). We studied consecutive patients with histologically proven hilar cholangiocarcinoma, who were referred for biliary drainage by ERCP in our center between 2015 and 2023. Automated reconstruction of bile ducts from CT images was performed using an artificial intelligence software (Synapse 3D 6.7, Fujifilm, Tokyo, Japan). We compared the Bismuth-Corlette classification assessed by ERCP (gold-standard), MRCP, CT-scan, and 3DR by computing exact percentage and weighted Kappa agreements. We included 62 patients. As compared with ERCP, CT-scan without 3DR had an exact agreement of 48% and had a moderate weighted Kappa agreement (weighted Kappa 0.47; 95%CI: 0.27-0.67). The MRCP had an exact agreement of 52% and a moderate weighted Kappa agreement (weighted Kappa 0.57; 95%CI: 0.39-0.76). The 3DR had an exact agreement of 60%, and a strong weighted Kappa agreement (weighted Kappa 0.72; 95%CI: 0.60-0.85). 3DR is highly concordant with ERCP in assessing the extent of pCCA.

#5

Gross Intrahepatic Mass Formation Predicts the Primary Site of Perihilar Cholangiocarcinoma Based on Molecular Pathologic Studies.

Journal of hepato-biliary-pancreatic sciences2026 Feb 01

Intrahepatic cholangiocarcinoma (iCCA) and extrahepatic cholangiocarcinoma (eCCA) are clinically and genetically distinct. However, the classification of perihilar cholangiocarcinoma (phCCA) with an intrahepatic tumor mass remains unclear. This study aimed to position phCCA near the hilar plate (hCCA) within an extrahepatic-intrahepatic framework using pathological and molecular analyses. Among 357 resected invasive CCAs, 100 hCCAs were histologically classified as either hCCA with (hCCA-M) or hCCA without (hCCA-NM) a grossly evident intrahepatic mass. Transcriptomic comparison of 9 typical eCCAs and 39 mass-forming iCCAs identified three contextual markers, which were examined by immunohistochemistry in 309 additional cases. Among 100 hCCAs, 85 were hCCA-NM and 15 hCCA-M. Claudin 18 (CLDN18) and mesothelin (MSLN) were identified as extrahepatic contextual markers, and serpin family A member 1 (SERPINA1) as an intrahepatic contextual marker. SERPINA1 was more highly expressed in hCCA-M than in hCCA-NM, regardless of microscopic liver parenchymal invasion, whereas CLDN18 and MSLN were similarly expressed in both. Cluster analysis revealed that hCCA-NM clustered with eCCA, whereas hCCA-M clustered with iCCA. Gross intrahepatic mass formation indicates an intrahepatic contextual profile and provides a useful criterion for subclassifying hCCA. This contextual framework shows that hCCA-M and hCCA-NM represent biologically distinct tumor groups.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC823 artigos no totalmostrando 190

2025

Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study.

BJS open
2026

The rationale against a "mandatory" extended hepatectomy in perihilar cholangiocarcinoma: meta-analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2026

Predicting recurrence in patients with node-negative perihilar cholangiocarcinoma after an R0 resection.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2026

ASO Visual Abstract: Impact of Additional Resection on Outcomes in Patients with Positive Proximal Margin of Perihilar Cholangiocarcinoma - A Systematic Review and Network Meta-analysis.

Annals of surgical oncology
2026

Role of Endoscopy in Malignant Biliary Obstruction.

Diagnostics (Basel, Switzerland)
2026

Differences in Right Hepatic Duct Length Among Left-Sided Hepatectomies: Conventional Hepatectomy Versus Extended Hepatectomy Versus Trisectionectomy.

Journal of hepato-biliary-pancreatic sciences
2025

Elevated Creatine Kinase as a Marker for Aggressive GI Malignancy.

Journal of community hospital internal medicine perspectives
2026

Long-term survival after multidisciplinary treatment including durvalumab for recurrent perihilar cholangiocarcinoma.

Clinical journal of gastroenterology
2026

ASO Author Reflections: Reassessing the Value of Additional Proximal Margin Resection for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2026

Focal Hepatic Steatosis Mimicking a Hilar Tumor With Rapid Resolution After Glycemic Control: A Case Report.

Cureus
2026

[Technical points of portal vein resection and reconstruction for perihilar cholangiocarcinoma: based on the experience of Nagoya University Hospital].

Zhonghua wai ke za zhi [Chinese journal of surgery]
2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma.

Journal of visualized experiments : JoVE
2026

Preoperative bilateral drainage for perihilar cholangiocarcinoma via endoscopic ultrasound-guided hepaticogastrostomy using a novel side-hole plastic stent.

Endoscopy
2026

The rise of transplant oncology in primary liver cancer and metastatic disease.

Hepatology (Baltimore, Md.)
2026

Neoadjuvant chemotherapy versus upfront surgery for perihilar cholangiocarcinoma: a propensity score matching analysis.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2026

Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
2026

Surgical Outcomes of Non-Benchmark Perihilar Cholangiocarcinoma: A Multicenter Study from High-Volume Centers in Japan.

Annals of surgery
2026

Is Extended Lymphadenectomy in Biliary Tract Cancers Justified? A Retrospective Comparative Study of Gallbladder Cancer, Perihilar and Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology
2026

Impact of Additional Resection on Outcomes in Patients with Positive Proximal Margin of Perihilar Cholangiocarcinoma: A Systematic Review and Network Meta-analysis.

Annals of surgical oncology
2026

Considerations for improving generalizability and robustness of predictive models in perihilar cholangiocarcinoma.

Hepatobiliary surgery and nutrition
2026

Reconsidering predictive models in perihilar cholangiocarcinoma.

Hepatobiliary surgery and nutrition
2026

Differential effects of preoperative cholangitis and biliary stenting in long-term survival of patients undergoing surgery for perihilar cholangiocarcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2026

Oncologic impact of additional pancreaticoduodenectomy for distal margin-positive perihilar cholangiocarcinoma: a multi-decade single-center analysis.

Surgery today
2026

Evaluating the performance of multiphasic CT in assessing biliary tumor extent and resectability in perihilar cholangiocarcinoma: insights from a Western population.

Abdominal radiology (New York)
2026

Optimizing Risk Stratification in Elderly Patients With Perihilar Cholangiocarcinoma: Bridging Objective Indices and Holistic Assessment.

Journal of hepato-biliary-pancreatic sciences
2026

A Rare and Aggressive Klatskin Tumor Revealed by Magnetic Resonance Cholangiopancreatography (MRCP): A Diagnostic Case Report.

Cureus
2026

Perihilar cholangiocarcinoma: microscopic positive margin and its clinical relevance.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Prognostic impact of individual resection and dissection margins in resected perihilar cholangiocarcinoma: retrospective study.

BJS open
2026

Value of albumin-bilirubin grade for 90-day mortality and long-term outcomes in patients with perihilar cholangiocarcinoma: a multicenter retrospective cohort study.

Therapeutic advances in medical oncology
2026

Gross Intrahepatic Mass Formation Predicts the Primary Site of Perihilar Cholangiocarcinoma Based on Molecular Pathologic Studies.

Journal of hepato-biliary-pancreatic sciences
2026

Robotic Right Trisectionectomy, Main Biliary Confluence Resection, Lymphadenectomy, and Hepaticojejunal Reconstruction for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2026

Eosinophilic cholangitis without peripheral eosinophilia presenting as a localized bile duct stricture mimicking perihilar cholangiocarcinoma.

Clinical journal of gastroenterology
2026

[Klatskin tumors-differentiated surgical treatment].

Chirurgie (Heidelberg, Germany)
2026

[Operative and oncological outcomes after vascular resection for perihilar cholangiocarcinoma].

Chirurgie (Heidelberg, Germany)
2026

Chronological change in subcutaneous adipose tissue radiodensity as a predictor of surgical outcome in patients with perihilar cholangiocarcinoma undergoing major hepatectomy.

Hepatobiliary &amp; pancreatic diseases international : HBPD INT
2026

The impact of biliary drainage on chemotherapy initiation and survival in patients with non-resected perihilar cholangiocarcinoma: a population-based study in the Netherlands.

Scandinavian journal of gastroenterology
2026

Hypoalbuminemia as a prognostic marker for survival in biliary tract cancer: associations with tumor type, treatment and sex.

Journal of cancer research and clinical oncology
2026

Characteristics of late recurrences after hepatectomy for perihilar cholangiocarcinoma: a single-center cohort study.

BMC surgery
2025

Predictors and prognostic impact of textbook outcome in patients with biliary tract cancer after hepatectomy: a systematic review and meta-analysis.

International journal of surgery (London, England)
2026

Immediate Reconstruction of Pancretaticogastrostomy Following Hepatopancreatoduodenectomy for Biliary Tact Cancer: A Single-Center Review of 33 Consecutive Patients.

Annals of gastroenterological surgery
2025

Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation.

Frontiers in oncology
2025

Conversion Surgery after Complete Response to Immune Checkpoint Inhibitor-Based Sequential Chemotherapy for Initially Unresectable Perihilar Cholangiocarcinoma: A Case Report.

Surgical case reports
2026

Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential.

Targeted oncology
2026

Intense 68 Ga-PSMA-11 Uptake of Perihilar Cholangiocarcinoma.

Clinical nuclear medicine
2026

Robotic right hemihepatectomy for perihilar cholangiocarcinoma (with video).

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
2025

Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study.

Frontiers in oncology
2025

An Unusual Cause of Hematemesis in a Patient Previously Treated for Cholangiocarcinoma.

The Korean journal of helicobacter and upper gastrointestinal research
2026

Robotic-assisted surgery improves short-term outcomes of perihilar cholangiocarcinoma: a referral-center cohort study.

Surgical endoscopy
2025

Long-term survival outcome of portal vein embolization in patients with perihilar cholangiocarcinoma: a retrospective cohort study.

World journal of surgical oncology
2025

Proton Beam Therapy for Intrahepatic and Perihilar Cholangiocarcinoma: A Multicenter Prospective Registry Study: Potential Candidates for High-Dose Proton Beam Therapy.

International journal of radiation oncology, biology, physics
2025

Failure-to-rescue as a determinant of overall survival following resection for perihilar cholangiocarcinoma.

JHEP reports : innovation in hepatology
2026

Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count.

Surgery
2025

Left extended hepatectomy with biliary resection and reconstruction for hilar cholangiocarcinoma in patient with Osler-Rendu-Weber disease: a case report and review of literature.

Updates in surgery
2026

Preoperative Prediction of Portal Vein Thrombosis After Right-Sided Hepatectomy for Perihilar Cholangiocarcinoma.

World journal of surgery
2025

Targeted cholangioscopy-guided biopsies through the mesh of biliary metal stents - a challenging diagnosis of perihilar cholangiocarcinoma.

Endoscopy
2025

Human chorionic gonadotropin-positive cystic duct carcinoma with trophoblastic differentiation that exhibited an aggressive clinical course.

BMJ case reports
2025

Significance of Intraoperative Lavage Cytology in Perihilar Cholangiocarcinoma.

Annals of gastroenterological surgery
2025

Hepatocellular Carcinoma Confined to the Bile Duct without Hepatic Mass or Jaundice: A Case Report.

Surgical case reports
2025

Preoperative Liver Function as a Predictor of Postoperative Liver Failure in Perihilar Cholangiocarcinoma.

In vivo (Athens, Greece)
2025

Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.

Anticancer research
2025

Prognostic Impact of Additional Resection of Bile Duct Margins in Radical Resection for Perihilar Cholangiocarcinoma.

Anticancer research
2026

ASO Author Reflections: Application of Robotic Surgery for the Most Complex Hepatobiliary Cancer Resection: The Feasibility and Future Role of Robotic Technology in Treatment of Bismuth Type IV Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2026

ASO Author Reflections: Technical Challenges and Solutions in Pancreaticoduodenectomy After Perihilar Cholangiocarcinoma Surgery.

Annals of surgical oncology
2025

Tumor invasion loci in resected margins of perihilar cholangiocarcinoma and their impact on survival: a retrospective 13-year longitudinal cohort study.

World journal of surgical oncology
2025

Primary percutaneous stenting for palliative biliary drainage of patients with malignant hilar biliary obstruction: TESLA trial.

JHEP reports : innovation in hepatology
2026

Surgical Technique and Feasibility of Pancreaticoduodenectomy after Surgery for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Robotic extended right hepatectomy for Bismuth-Corlette IIIa perihilar cholangiocarcinoma (with video).

Journal of visceral surgery
2026

Robotic Resection of Type IV Perihilar Cholangiocarcinoma. Moving Toward the Most Complex Minimally Invasive Technique in Biliary Cancer Surgery.

Annals of surgical oncology
2025

Tumor Serosal Invasion in Perihilar Cholangiocarcinoma: A Lethal But Overlooked Feature.

Annals of surgery
2026

Stratifying cholangiocarcinoma: tumor microenvironment, molecular drivers, and novel immunotherapeutic approaches.

Clinical and molecular hepatology
2025

Impact of resected-to-original middle hepatic vein length proportion on posthepatectomy liver failure after right-sided hepatectomy for perihilar cholangiocarcinoma.

Surgical oncology
2025

ASO Visual Abstract: Central Hepatectomy As an Alternative: A Comparative Study with Conventional Major Hepatectomy for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2026

ASO Authors Reflections: Could Robotics, 3D Imaging, and Liver Venous Deprivation Potentially Redefine Surgical Standards for Perihilar Cholangiocarcinoma?

Annals of surgical oncology
2025

ASO Author Reflections: Vascular Resection in Perihilar Cholangiocarcinoma Surgery.

Annals of surgical oncology
2025

ASO Visual Abstract: Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Prognostic implications of morphological subtypes in a surgical cohort of perihilar cholangiocarcinoma: the overriding impact of nodal status.

International journal of clinical oncology
2025

Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research.

Tomography (Ann Arbor, Mich.)
2025

Tumor necrosis facilitates perihilar cholangiocarcinoma metastasis by ANGPTL6-augmented vessel permeability and tumor dissemination.

JHEP reports : innovation in hepatology
2026

Efficacy of three-dimensional fast spin echo T2-weighted magnetic resonance imaging (Cube) for evaluating the longitudinal spread of perihilar cholangiocarcinoma after endoscopic biliary stenting: a diagnostic study.

International journal of surgery (London, England)
2025

Alveolar Echinococcosis Mimicking Perihilar Cholangiocarcinoma Leading to Liver Transplant: A Case Report.

The American journal of case reports
2026

FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study.

Hepatology research : the official journal of the Japan Society of Hepatology
2025

Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Central Hepatectomy as an Alternative: A Comparative Study with Conventional Major Hepatectomy for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

ASO Author Reflections: Central Hepatectomy for Perihilar Cholangiocarcinoma: A Tailored Alternative to Conventional Major Hepatectomy.

Annals of surgical oncology
2025

Outcomes following exploratory surgery without subsequent resection in perihilar cholangiocarcinoma: A nationwide analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Robotic resection of Bismuth type II perihilar cholangiocarcinoma with tangential portal vein resection and reconstruction.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
2025

Discovery of a Copy-neutral Loss of Heterozygosity Pattern in Perihilar Cholangiocarcinoma With Potential Prognostic Value.

Anticancer research
2025

[Comparative study of clinicopathological features and prognosis of biliary tract cancer in different locations].

Zhonghua wai ke za zhi [Chinese journal of surgery]
2025

Liver Transplantation for Cancer-Current Challenges and Emerging Solutions.

Journal of clinical medicine
2025

A pilot study showcasing the difficulties in endoscopic biliary drainage using uncovered self-expanding metal stents for resectable perihilar cholangiocarcinoma.

Scandinavian journal of gastroenterology
2026

A Novel Transplant Approach for Locally Advanced Unresectable Perihilar Cholangiocarcinoma: The SURE-LT Concept.

Annals of surgery
2025

Do Trisectionectomies Improve Outcomes for Localized Bismuth-Corlette Type II and III Perihilar Cholangiocarcinoma? Insights From a Nationwide French Cohort Study.

Annals of surgery
2025

Emergency covered stent implantation for portal vein tear during balloon angioplasty in a patient with advanced perihilar cholangiocarcinoma.

Journal of cardiothoracic surgery
2025

Comparison of prognostic factors and their differences in intrahepatic, hilar, and distal cholangiocarcinoma: A systematic review and meta-analysis.

World journal of gastrointestinal oncology
2025

Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors.

Annals of surgical oncology
2025

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

BMJ open
2025

Perioperative and Oncological Outcome in Patients Undergoing Curative-Intent Liver Resection for Cholangiocarcinoma in the Context of Osteopenia.

Cancers
2025

Impact of preoperative biliary drainage on postoperative outcomes in patients who undergo major hepatectomy after portal vein embolization for perihilar cholangiocarcinoma.

Surgery today
2025

Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinoma.

Hepatology (Baltimore, Md.)
2025

FGFR2-Rearrangement in Intrahepatic and Extrahepatic Cholangiocarcinoma and Prognostic Analysis.

International journal of general medicine
2025

Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma.

BMC gastroenterology
2025

Liver transplantation as a new treatment option for perihilar cholangiocarcinoma and colorectal liver metastases: a review.

International journal of clinical oncology
2025

Robotic Type II Perihilar Cholangiocarcinoma Resection: Technique of Hilar Plate Unification Ductoplasty.

Annals of surgical oncology
2025

Prediction of Distal Ductal Margin Status Using the Distance Between the Posterior Superior Pancreaticoduodenal Artery and the Tumor in Surgery for Perihilar Cholangiocarcinoma.

World journal of surgery
2025

Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinoma.

Scientific reports
2025

Surgical Case of Metachronous Occurrence of Intracholecystic Papillary Neoplasm in the Remnant Cystic Duct 19 Years after Cholecystectomy.

Surgical case reports
2025

Hepatic clearance of remnant liver for assessing lobar difference of liver function in patients with perihilar cholangiocarcinoma: single center experience.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Development of the Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) Score.

Annals of surgery
2025

Minimally Invasive Surgery for Perihilar Cholangiocarcinoma-A Review of the Current Literature.

Journal of clinical medicine
2025

Update to the role of staging laparoscopy in the assessment of resectability of perihilar cholangiocarcinoma: have improvements in cross-sectional and functional imaging rendered it redundant?

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Oncologic impact of perineural invasion in perihilar cholangiocarcinoma: an international multicenter study.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Cachexia index as a prognostic marker in patients undergoing biliary tract cancer resection.

Surgery today
2025

Recommendations on Perihilar Cholangiocarcinoma. The Milan Jury-Based Consensus.

Annals of surgery
2025

Depth of Liver Invasion as a Novel Predictor for Outcome of Perihilar Cholangiocarcinoma.

The American journal of surgical pathology
2025

Better Outcomes by Measuring Function? Predicting Functional Future Liver Remnant Using Tc-GSA SPECT/CT in Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Impact of hepatospleno volume ratio on postoperative chronic liver failure after major hepatectomy for perihilar cholangiocarcinoma.

Annals of gastroenterological surgery
2025

Migration of a Stent-graft into the Duodenum after Stent-graft Placement for Proper Hepatic Artery Pseudoaneurysm: A Case Report.

Interventional radiology (Higashimatsuyama-shi (Japan)
2025

Interobserver variability in lymph node evaluation with endoscopic ultrasonography in cholangiocarcinoma.

Endoscopy international open
2025

Prognostic impact of lymph node and surgical margin in patients with perihilar cholangiocarcinoma.

European journal of medical research
2025

Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trial.

BMC cancer
2025

Intraoperative blood loss in perihilar cholangiocarcinoma: should we aim below a certain cut-off?

Hepatobiliary surgery and nutrition
2025

Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis.

Hepatobiliary surgery and nutrition
2025

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology
2025

Pathological Complete Response after Pembrolizumab Treatment for Unresectable Perihilar Cholangiocarcinoma with High Microsatellite Instability: A Case Report.

Surgical case reports
2025

Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage.

Therapeutic advances in gastroenterology
2025

Comparison of Al 18 F-NOTA-FAPI-74 and 18 F-FDG PET/CT in the Evaluation and Staging of Hepatobiliary Malignancies : A Single-center Prospective Study.

Clinical nuclear medicine
2025

Is it time to define the scope of safety for robotic resection in perihilar cholangiocarcinoma surgery? A propensity score matching based analysis of a single center experience.

Annals of hepato-biliary-pancreatic surgery
2025

Preoperative management and resectability criteria in perihilar cholangiocarcinoma.

The British journal of surgery
2025

Western and Eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre study.

BJS open
2025

Spexin expression in the human bile duct and perihilar cholangiocarcinoma.

Peptides
2025

Prognostic significance of the cachexia index for patients with perihilar cholangiocarcinoma.

Surgery
2025

Prognostic Impact of Diabetes Mellitus and Extended Hepatectomy on Perihilar Cholangiocarcinoma.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches
2025

ASO Author Reflections: Application of Robotic Technique in Resection of Perihilar Cholangiocarcinoma. A Step Toward New Alternative Approach in Bile Duct Cancer Surgery.

Annals of surgical oncology
2025

TRANSMIT: Utilizing discarded livers from donors with a history of cancer for patients lacking access to standard allocation - A compassionate use exploratory study.

Contemporary clinical trials communications
2025

Safety and efficacy of pancreaticogastrostomy for hepatopancreatoduodenectomy compared to pancreaticojejunostomy for perihilar cholangiocarcinoma.

World journal of surgical oncology
2026

Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis.

Hepatology (Baltimore, Md.)
2025

ASO Author Reflections: Perihilar Cholangiocarcinoma-Optimizing Outcomes.

Annals of surgical oncology
2025

Annual report of Japanese biliary tract cancer registry from 2021: Focus on the rate of R0 resection, postoperative complications, and site of lymph node metastasis.

Journal of hepato-biliary-pancreatic sciences
2025

Robotic surgery for perihilar cholangiocarcinoma: a concise systematic review.

Surgical endoscopy
2025

[Frozen sections in hepatobiliary surgery].

Chirurgie (Heidelberg, Germany)
2025

Prognostic Significance of Sarcopenia in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

Cancers
2025

Robotic Left Hepatectomy for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Successful Left Trisectionectomy for Intrahepatic Cholangiocarcinoma in a Patient with a Right-Sided Round Ligament: A Case Report.

Surgical case reports
2025

Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience.

Annals of surgical oncology
2025

Safety and efficacy of living donor liver transplantation for unresectable perihilar cholangiocarcinoma: A single center prospective study.

Journal of hepato-biliary-pancreatic sciences
2025

Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report.

Human vaccines &amp; immunotherapeutics
2025

Central hepatectomy for perihilar cholangiocarcinoma: an alternative technique for parenchymal-sparing hepatectomy to prevent post-hepatectomy liver failure.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Preoperative Imaging Assessment and Staging of Perihilar Cholangiocarcinoma: Tips and Pitfalls.

Journal of the Korean Society of Radiology
2025

New Tumor Classification Using Invasion Depth in Biliary Tract Cancer Around the Cystic Duct Junction.

Annals of surgery
2025

High preoperative Glasgow prognostic score increases a risk of hospital mortality in elderly patients with perihilar cholangiocarcinoma.

Journal of hepato-biliary-pancreatic sciences
2024

[A Resected Case of Simultaneous Perihilar Cholangiocarcinoma and Hepatocellular Carcinoma with Preoperative Diagnosis].

Gan to kagaku ryoho. Cancer &amp; chemotherapy
2025

Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis.

Cancers
2025

The impact of resection margin status according to lymph node metastasis on the survival outcome of perihilar cholangiocarcinoma.

American journal of surgery
2025

Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma.

Transplantation direct
2025

Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach.

Hepatobiliary surgery and nutrition
2025

Diagnosing hilar cholangiocarcinoma: ERCP with cholangioscopy.

Revista espanola de enfermedades digestivas
2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb.

Journal of visualized experiments : JoVE
2025

Long-term outcomes of hepatopancreatoduodenectomy for perihilar cholangiocarcinoma: A comparative study with conventional hepatectomy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Failure to Rescue After Resection of Perihilar Cholangiocarcinoma: Can the Pig Fatten if Weighed More Often?

Annals of surgical oncology
2025

OPTIMIZING PERIOPERATIVE CARE FOR PERIHILAR CHOLANGIOCARCINOMA: THE CRUCIAL ROLE OF MULTIDISCIPLINARY MANAGEMENT, NEOADJUVANT THERAPY, AND INTERVENTIONAL RADIOLOGY.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
2025

Association between the Achievement of Textbook Outcomes in Liver Surgery and Overall Survival in Perihilar Cholangiocarcinoma Patients following Major Hepatectomy: A Multicenter Study.

Digestive diseases (Basel, Switzerland)
2025

Circulating tumor cell dynamic detecting to optimize neoadjuvant chemotherapy combined with liver transplantation in perihilar cholangiocarcinoma.

Hepatobiliary &amp; pancreatic diseases international : HBPD INT
2025

ASO Author Reflections: The Impact of Time to Surgery for Survival Outcome in Patients with Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2024

The role of surgical approach in recovery from extrahepatic cholangiocarcinoma: hemihepatectomy vs. pancreatoduodenectomy.

Langenbeck's archives of surgery
2025

Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2024

Screening and molecular mechanism research on bile microRNAs associated with chemotherapy efficacy in perihilar cholangiocarcinoma.

iScience
2024

Preoperative factors predicting outcomes in patients with suspected perihilar cholangiocarcinoma referred for curative resection- a single-center 10-year experience.

Langenbeck's archives of surgery
2025

ASO Author Reflections: Efficacy of Adjuvant Chemotherapy Following Major Hepatectomy for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2025

Postoperative factors predicting outcomes in patients with Perihilar cholangiocarcinoma undergoing curative resection-a 10-year single-center experience.

Scandinavian journal of gastroenterology
2024

Predictors of Post-Hepatectomy Liver Failure in Klatskin Tumors: The Role of Preoperative Glucose, Future Liver Remnant to Spleen Ratio, and Early Bilirubin Monitoring.

Diagnostics (Basel, Switzerland)
2024

Impact of aging on hepatic reserve after preoperative portal vein embolization in hepatectomy for perihilar cholangiocarcinoma.

Asian journal of surgery
2024

Perihilar Cholangiocarcinoma Originating in Peribiliary Glands: Insights from a Case without Precancerous Lesions.

The American journal of case reports
2025

Risks and use of ERCP during the diagnostic workup in a national cohort of biliary cancer.

Surgical endoscopy
2025

Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and station.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Gemcitabine-cisplatin induction treatment in patients with locally advanced perihilar cholangiocarcinoma (IMPACCA): A prospective registration study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Time to Surgery Does Not Affect the Survival Outcome in Patients with Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2024

Multidisciplinary Approach to Perihilar and Intrahepatic Cholangiocarcinoma: A Single-Center Experience.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
2025

Prognostic impact of osteosarcopenia on postoperative outcomes in patients with biliary tract cancer.

Surgery today
2025

A Multicenter Retrospective Study on Adjuvant S-1 Chemotherapy Versus Observation Following Major Hepatectomy for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2024

The impact of positive resection margin in perihilar cholangiocarcinoma, ductal margin vs radial margin.

Langenbeck's archives of surgery
2025

Primary percutaneous metal stenting above the ampulla in resectable perihilar cholangiocarcinoma.

Acta chirurgica Belgica
2025

Acceptable number of cholangioscopy-guided biopsies for diagnosing perihilar cholangiocarcinoma.

Revista espanola de enfermedades digestivas
2024

Perihilar cholangiocarcinoma masquerading as intrahepatic cholestasis of pregnancy: a case report and review of the literature.

Frontiers in medicine
2025

Establishment a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with microvascular invasion.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

ASO Author Reflections: Liver Failure Dominates the Risk of Failure to Rescue After Surgery for Perihilar Cholangiocarcinoma.

Annals of surgical oncology
2024

Corrigendum: Effect of sarcopenia on postoperative ICU admission and length of stay after hepatic resection for Klatskin tumor.

Frontiers in oncology
2024

Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report.

World journal of gastrointestinal oncology
2025

Liver transplantation for primary and secondary liver tumors: Patient-level meta-analyses compared to UNOS conventional indications.

Hepatology (Baltimore, Md.)
2024

Left hepatectomy extended to segments 1, 5 and 8 with reconstruction of the right branch of the hepatic artery for Rennes type X perihilar cholangiocarcinoma.

Journal of visceral surgery
2024

Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma.

Cancers
Ver todos os 823 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Colangiocarcinoma peri-hilar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Colangiocarcinoma peri-hilar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Differences in Right Hepatic Duct Length Among Left-Sided Hepatectomies: Conventional Hepatectomy Versus Extended Hepatectomy Versus Trisectionectomy.
    Journal of hepato-biliary-pancreatic sciences· 2026· PMID 41796438mais citado
  2. Long-term survival after multidisciplinary treatment including durvalumab for recurrent perihilar cholangiocarcinoma.
    Clinical journal of gastroenterology· 2026· PMID 41779092mais citado
  3. The rise of transplant oncology in primary liver cancer and metastatic disease.
    Hepatology (Baltimore, Md.)· 2026· PMID 41746604mais citado
  4. Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver· 2026· PMID 41724623mais citado
  5. Gross Intrahepatic Mass Formation Predicts the Primary Site of Perihilar Cholangiocarcinoma Based on Molecular Pathologic Studies.
    Journal of hepato-biliary-pancreatic sciences· 2026· PMID 41622428mais citado
  6. Curative resection of borderline resectable perihilar cholangiocarcinoma following neoadjuvant gemcitabine and cisplatin plus durvalumab immunochemotherapy: a case report.
    J Surg Case Rep· 2026· PMID 41993112recente
  7. Case Report: Preoperative treatment of portal hypertension by splenic artery embolization for safe major hepatectomy: experience in three patients.
    Front Surg· 2026· PMID 41960211recente
  8. ASO Visual Abstract: Laparoscopic Right Hemi-hepatectomy Plus Total Caudate Lobectomy with Portal Vein Resection and Reconstruction for Perihilar Cholangiocarcinoma.
    Ann Surg Oncol· 2026· PMID 41954714recente
  9. The selection and strategy of stents in endoscopic drainage of unresectable perihilar cholangiocarcinoma: a meta-analysis.
    BMC Surg· 2026· PMID 41947135recente
  10. A case of perihilar cholangiocarcinoma with peritoneal dissemination that achieved a pathological complete response using immune checkpoint inhibitors: A case report.
    Int Cancer Conf J· 2026· PMID 41929550recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:99978(Orphanet)
  2. MONDO:0003345(MONDO)
  3. GARD:10175(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q475260(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Colangiocarcinoma peri-hilar
Compêndio · Raras BR

Colangiocarcinoma peri-hilar

ORPHA:99978 · MONDO:0003345
Prevalência
1-9 / 100 000
Herança
Not applicable
CID-10
C24.0 · Neoplasia maligna das vias biliares extra-hepáticas
CID-11
Ensaios
17 ativos
Início
Adult
Prevalência
0.0 (Europe)
MedGen
UMLS
C0206702
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades